Thus, this study aimed to evaluate the plasma MPO and ANGPTL6 levels in both obese and T2D patients and to assess their association with the biochemical markers of obesity, inflammation, and atherosclerosis. This evidence concerns the gene ANGPTL6 and atherosclerosis.